BSETrident Texofab LtdMediumNeutral
Announced Mon, 12 May · 21:17 IST

Conversion of 4,08,333 warrants into 4,08,333 equity shares of face value of Rs. 10/- each.

Warrants ConvertedFund Raising View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Trident Texofab Limited has converted 4,08,333 warrants into an equal number of equity shares of face value Rs. 10 each, at an issue price of Rs. 70 per share (including a premium of Rs. 60 per share). The company received the balance 75% amount of Rs. 52.50 per warrant, aggregating to Rs. 2.14 crore, from 17 allottees belonging to the Non-Promoter, Public Category on a preferential basis. The warrants were originally allotted on December 23, 2024, at Rs. 70 each (25% upfront, 75% on conversion). Post-allotment, the paid-up equity capital has risen to Rs. 13.97 crore, comprising 1,39,67,093 equity shares. Additionally, 19,40,150 warrants are still pending conversion.

Likely market impact

This is a routine partial conversion of previously allotted warrants, increasing the share count by about 3% and resulting in mild dilution for existing shareholders. The newly allotted shares will rank equally with existing shares, and further dilution is possible if the remaining 19.4 lakh warrants are also converted.